Issue 6/2019
Content (12 Articles)
What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?
Robert Peter Gale, Jane Apperley
Early Management of CML
Naranie Shanmuganathan, Timothy P. Hughes
Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia
Florence Rabian, Etienne Lengline, Delphine Rea
The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?
Naranie Shanmuganathan, Susan Branford
Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Minas P. Economides, David Rizzieri, Naveen Pemmaraju
Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: a Young International Society of Geriatric Oncology Review Paper
Kah Poh Loh, Maya Abdallah, Anita J. Kumar, Nina R Neuendorff, Saurabh Dahiya, Heidi D. Klepin
The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS)
David P. Steensma
Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO
Andrew T. Kuykendall, Eric Padron
Mutation-Driven Therapy in MDS
David M. Swoboda, David A. Sallman
Driving the CAR to the Bone Marrow Transplant Program
Hema Dave, Lauren Jerkins, Patrick J Hanley, Catherine M Bollard, David Jacobsohn
Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders
Geoffrey Shouse, Liana Nikolaenko